2006
DOI: 10.1089/vim.2006.19.340
|View full text |Cite
|
Sign up to set email alerts
|

HPV16 Variants in Squamous Intraepithelial Lesions in Human Immunodeficiency Virus–Negative and –Positive Brazilian Women

Abstract: Emerging evidence supports the role of human papillomavirus (HPV) intratype variations in the development of cervical lesions in immunocompetent women, but few studies investigated HPV16 variants in human immunodeficiency virus (HIV)-positive women. This is the first study in Brazil evaluating HPV16 variants in women with (n = 19) and without (n = 22) HIV infection, as well as cervical lesions. Although non-European variants presented an almost 3-fold increase (13.6% vs. 36.8%) among HIV-positive women, associ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
1
3
0
Order By: Relevance
“…Seven out of eleven HPV16 sequences from cervical samples analyzed in the present study were classified as variant A. This variant distribution is in agreement with previous Brazilian studies, which observed that 34% (Gheit et al, 2006) to 65.8% (Freitas et al, 2014) of the HPV16 isolates are classified as HPV16_A variant. We could ascribe the SNPs in the different isolates here sequenced to the differential variant signatures (Smith et al, 2011).…”
Section: Discussionsupporting
confidence: 92%
“…Seven out of eleven HPV16 sequences from cervical samples analyzed in the present study were classified as variant A. This variant distribution is in agreement with previous Brazilian studies, which observed that 34% (Gheit et al, 2006) to 65.8% (Freitas et al, 2014) of the HPV16 isolates are classified as HPV16_A variant. We could ascribe the SNPs in the different isolates here sequenced to the differential variant signatures (Smith et al, 2011).…”
Section: Discussionsupporting
confidence: 92%
“…Another study, with women from Northern Brazil found NE variants associated with high-grade cervical lesions [42]. However, HPV16 NE variants were detected at similar frequencies in low grade lesions (6/41, 14.6%) and in high grade cases (4/41, 9.7%) in a study conducted in São Paulo, also in Southeastern Brazil [39] and HPV16 NE and E variants have been detected at similar frequencies among the cytological finds (atypical squamous or glandular cells of undetermined significance, cytological alterations suggesting HPV infection, CIN, squamous cell carcinoma, and adenocarcinoma) in women from Central Brazil [38], not supporting a role for NE HPV16 variants as at increased risk for CC. Nevertheless, there is other evidence that HPV16 NE variants have elevated risks for CIN3 and cancer, although much of the effect was related to the increased risk with the AA (D) lineage [25], [56], [66], and there appears to be geographic complexity [58].…”
Section: Discussionmentioning
confidence: 91%
“…HIV infection increases the risk of cervical infection due to high-risk HPV genotypes that induces high-grade cervical squamous intraepithelial lesions (HSILs), which in turn leads to the development of pre-invasive cervical lesions and invasive cervical cancer (ICC) [23][24][25]. HIV infection could alter the natural history of HPV infection through decreasing the self-clearance rate of infection and increasing progression to high grade and invasive lesions [24].…”
Section: Introductionmentioning
confidence: 99%
“…HIV infection could alter the natural history of HPV infection through decreasing the self-clearance rate of infection and increasing progression to high grade and invasive lesions [24]. Furthermore, the incidence of HPV infection is three times higher in HIV-positive women [25], and can cause cervical cancer than their counterparts [26]. Nonetheless, with the exception of the systematic review and meta-analysis done in Kenya [27], evidences in this regard showing the burden and molecular distribution of HPV in low and middle income countries (LMICs) is limited [28].…”
Section: Introductionmentioning
confidence: 99%